Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: safety and survival
| Autor: | Mazza, S., Invernizzi, F., Iavarone, M., Zavaglia, C., Maggi, U., Cesarini, L., Antonelli, B., Airoldi, A., Manini, M.A., Sangiovanni, A., Rossi, G., Donato, M.F., Belli, L.S., Lampertico, P. |
|---|---|
| Zdroj: | In Digestive and Liver Disease February 2019 51 Supplement 1:e35-e35 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect